House Panel To Subpoena AbbVie Documents On Price, Patent Tactics

The House Oversight Committee plans to subpoena AbbVie documents on how executives set prices for Humira, one of the world’s best-selling drugs, and the cancer drug Imbruvica, according to a release from Chair Carolyn Maloney (D-NY). The subpoena is part of an investigation started by the late Rep. Elijah Cummings (D-MD) in January of 2019. Cummings requested documents from a dozen companies on pricing practices, executive incentives, research and development spending and patent strategies. Of those companies, only AbbVie received...